The molecular biology and therapeutic potential of Nrf2 in leukemiaAtefeh Khodakarami, Farhad Jadidi-Niaragh, Sara Adibfar et al.|Cancer Cell International|2022Cited by 46
The prognostic and therapeutic potential of HO-1 in leukemia and MDSMohammad Reza Sadeghi, Farhad Jadidi-Niaragh, Mehrdad Fathi et al.|Cell Communication and Signaling|2023Cited by 35
Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticlesAbbas Ali Hosseinpour Feizi, Farhad Jadidi-Niaragh, Sajjad Vakili‐Samiani et al.|Journal of Drug Delivery Science and Technology|2022Cited by 17
Expression level of immune checkpoint inhibitory factors in preeclampsiaSahar Madadi, Sina Mohammadinejad, Amin Alizadegan et al.|Human Immunology|2022Cited by 16
Targeting the CTLA-4/B7 axes in glioblastoma: preclinical evidence and clinical interventionsMehrdad Fathi, Farhad Jadidi-Niaragh, Seyed‐Mostafa Razavi et al.|Expert Opinion on Therapeutic Targets|2022Cited by 16